Medicine and Dentistry
Community Pharmacy
100%
Gestagen
71%
Emergency Contraception
71%
Reproductive Public Health
60%
Woman
57%
Evaluation Study
52%
Intracranial Hypertension
50%
Randomized Controlled Trial
50%
Mannitol
50%
Dextran
50%
Brain Injury
50%
Clinical Trial
50%
Lamivudine
50%
Reverse-Transcriptase Inhibitor
50%
Abacavir
45%
Zidovudine
40%
Intracranial Pressure
31%
Pharmacist
28%
Patient
25%
Therapeutic Procedure
15%
Interferon Type I
15%
Health Service
14%
Hospital
12%
Sodium Chloride
12%
Urine
12%
Intravenous Drug Administration
12%
Arm
10%
Gene Expression
10%
Protein
10%
Interferon Alfa
10%
Follow up
9%
Awareness
7%
Observation
7%
Research Design
7%
Motivation
7%
Self Concept
7%
Screening
7%
Study Participant
7%
Consultation
7%
Monitoring
7%
Sodium
6%
Intensive Care Unit
6%
Serum
6%
Patient Referral
6%
Measurement
6%
Blood Pressure
6%
Hormonal Contraception
5%
Abacavir/Lamivudine
5%
Placebo
5%
Patient Recruitment
5%
Nursing and Health Professions
Pharmacy
100%
Emergency Contraception
100%
Contraception
70%
Brain Injury
50%
Pill
50%
Mannitol
50%
Dextran
50%
Intracranial Hypertension
50%
Gestagen
50%
Consultation
35%
Intracranial Pressure
31%
Confidence Interval
20%
Woman
15%
Intravenous Drug Administration
12%
Dextran 70
12%
Sodium Chloride
12%
Control
10%
Health Center
10%
Hospital
6%
Intensive Care Unit
6%
Urine Osmolality
6%
Measurement
6%
Blood Pressure
6%
Dose
6%
Teaching Hospital
6%
Sodium Blood Level
6%
Tertiary Care Center
6%
Sodium Urine Level
6%
Pilot Study
6%
Urine Volume
6%
Time
5%
Standard
5%
Hormonal Contraception
5%
Prescription
5%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
55%
Lamivudine
50%
RNA Directed DNA Polymerase Inhibitor
50%
Pharmacology
50%
Emergency
50%
Syndrome
50%
Abacavir
45%
Zidovudine
40%
Interferon Type I
15%
Dextran 70
12%
Alpha Interferon
10%
Protein
10%
Abacavir Plus Lamivudine
5%
Placebo
5%
Study Design
5%
Interferon
5%
Patient Recruitment
5%
